Page last updated: 2024-09-05

dronedarone and Breast Neoplasms

dronedarone has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bane, A; Cescon, DW; Cockburn, JG; Elliott, MJ; Gwynne, WD; Haibe-Kains, B; Hassell, JA; Jerzak, KJ; Mak, TW; Safikhani, Z; Silvester, J; Thu, KL	1

Other Studies

1 other study(ies) available for dronedarone and Breast Neoplasms

Article	Year
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism. Scientific reports, 2018, 11-08, Volume: 8, Issue:1 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dronedarone; Drug Repositioning; Female; Humans; Mice; RNA, Small Interfering; Thyroid Hormone Receptors alpha; Xenograft Model Antitumor Assays	2018

Article

Year

The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.

Scientific reports, 2018, 11-08, Volume: 8, Issue:1

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dronedarone; Drug Repositioning; Female; Humans; Mice; RNA, Small Interfering; Thyroid Hormone Receptors alpha; Xenograft Model Antitumor Assays

2018